207 related articles for article (PubMed ID: 24485923)
1. Elevated YAP and its downstream targets CCN1 and CCN2 in basal cell carcinoma: impact on keratinocyte proliferation and stromal cell activation.
Quan T; Xu Y; Qin Z; Robichaud P; Betcher S; Calderone K; He T; Johnson TM; Voorhees JJ; Fisher GJ
Am J Pathol; 2014 Apr; 184(4):937-943. PubMed ID: 24485923
[TBL] [Abstract][Full Text] [Related]
2. Yin/Yang expression of CCN family members: Transforming growth factor beta 1, via ALK5/FAK/MEK, induces CCN1 and CCN2, yet suppresses CCN3, expression in human dermal fibroblasts.
Peidl A; Perbal B; Leask A
PLoS One; 2019; 14(6):e0218178. PubMed ID: 31170244
[TBL] [Abstract][Full Text] [Related]
3. A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ.
Tan G; Cao X; Dai Q; Zhang B; Huang J; Xiong S; Zhang Yy; Chen W; Yang J; Li H
Oncotarget; 2015 Apr; 6(11):8676-86. PubMed ID: 25895125
[TBL] [Abstract][Full Text] [Related]
4. CCN2 Mediates S1P-Induced Upregulation of COX2 Expression in Human Granulosa-Lutein Cells.
Hu LL; Chang HM; Yi Y; Liu Y; Taylor EL; Zheng LP; Leung PCK
Cells; 2019 Nov; 8(11):. PubMed ID: 31731760
[TBL] [Abstract][Full Text] [Related]
5. YAP and TAZ are essential for basal and squamous cell carcinoma initiation.
Debaugnies M; Sánchez-Danés A; Rorive S; Raphaël M; Liagre M; Parent MA; Brisebarre A; Salmon I; Blanpain C
EMBO Rep; 2018 Jul; 19(7):. PubMed ID: 29875149
[TBL] [Abstract][Full Text] [Related]
6. YAP knockdown inhibits proliferation and induces apoptosis of human prostate cancer DU145 cells.
Jin X; Zhao W; Zhou P; Niu T
Mol Med Rep; 2018 Mar; 17(3):3783-3788. PubMed ID: 29286134
[TBL] [Abstract][Full Text] [Related]
7. Atrial expression of the CCN1 and CCN2 proteins in chronic heart failure.
Bonda TA; Kamiński KA; Dziemidowicz M; Litvinovich S; Kożuch M; Hirnle T; Dmitruk I; Chyczewski L; Winnicka MM
Folia Histochem Cytobiol; 2012 Apr; 50(1):99-103. PubMed ID: 22532143
[TBL] [Abstract][Full Text] [Related]
8. CCN1-Yes-Associated Protein Feedback Loop Regulates Physiological and Pathological Angiogenesis.
Lee S; Ahad A; Luu M; Moon S; Caesar J; Cardoso WV; Grant MB; Chaqour B
Mol Cell Biol; 2019 Sep; 39(18):. PubMed ID: 31262999
[TBL] [Abstract][Full Text] [Related]
9. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
[TBL] [Abstract][Full Text] [Related]
10. Actin cytoskeleton regulates Hippo signaling.
Reddy P; Deguchi M; Cheng Y; Hsueh AJ
PLoS One; 2013; 8(9):e73763. PubMed ID: 24040060
[TBL] [Abstract][Full Text] [Related]
11. Neurofibromatosis 2 (NF2) controls the invasiveness of glioblastoma through YAP-dependent expression of CYR61/CCN1 and miR-296-3p.
Lee H; Hwang SJ; Kim HR; Shin CH; Choi KH; Joung JG; Kim HH
Biochim Biophys Acta; 2016 Apr; 1859(4):599-611. PubMed ID: 26923924
[TBL] [Abstract][Full Text] [Related]
12. YAP Subcellular Localization and Hippo Pathway Transcriptome Analysis in Pediatric Hepatocellular Carcinoma.
LaQuaglia MJ; Grijalva JL; Mueller KA; Perez-Atayde AR; Kim HB; Sadri-Vakili G; Vakili K
Sci Rep; 2016 Sep; 6():30238. PubMed ID: 27605415
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional and post-transcriptional regulation of CCN genes in failing heart.
Bonda TA; Kożuch M; Litvinovich S; Bialuk I; Taranta A; Lipiec P; Szymczyk E; Musiał WJ; Winnicka MM; Kamiński KA
Pharmacol Rep; 2015 Apr; 67(2):204-8. PubMed ID: 25712640
[TBL] [Abstract][Full Text] [Related]
14. Actin polymerization-enhancing drugs promote ovarian follicle growth mediated by the Hippo signaling effector YAP.
Cheng Y; Feng Y; Jansson L; Sato Y; Deguchi M; Kawamura K; Hsueh AJ
FASEB J; 2015 Jun; 29(6):2423-30. PubMed ID: 25690654
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder.
Liu JY; Li YH; Lin HX; Liao YJ; Mai SJ; Liu ZW; Zhang ZL; Jiang LJ; Zhang JX; Kung HF; Zeng YX; Zhou FJ; Xie D
BMC Cancer; 2013 Jul; 13():349. PubMed ID: 23870412
[TBL] [Abstract][Full Text] [Related]
16. S1P Stimulates Proliferation by Upregulating CTGF Expression through S1PR2-Mediated YAP Activation.
Cheng JC; Wang EY; Yi Y; Thakur A; Tsai SH; Hoodless PA
Mol Cancer Res; 2018 Oct; 16(10):1543-1555. PubMed ID: 29903770
[TBL] [Abstract][Full Text] [Related]
17. Myocardin-Related Transcription Factor A and Yes-Associated Protein Exert Dual Control in G Protein-Coupled Receptor- and RhoA-Mediated Transcriptional Regulation and Cell Proliferation.
Yu OM; Miyamoto S; Brown JH
Mol Cell Biol; 2016 Jan; 36(1):39-49. PubMed ID: 26459764
[TBL] [Abstract][Full Text] [Related]
18. Age-related elevation of HGF is driven by the reduction of fibroblast size in a YAP/TAZ/CCN2 axis-dependent manner.
Xiang Y; Qin Z; Yang Y; Fisher GJ; Quan T
J Dermatol Sci; 2021 Apr; 102(1):36-46. PubMed ID: 33648801
[TBL] [Abstract][Full Text] [Related]
19. Hip to the Game: YAP/TAZ is required for nonmelanoma skin cancers.
Miranda MM; Lowry WE
EMBO J; 2018 Sep; 37(17):. PubMed ID: 30037822
[TBL] [Abstract][Full Text] [Related]
20. Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma.
Nallet-Staub F; Marsaud V; Li L; Gilbert C; Dodier S; Bataille V; Sudol M; Herlyn M; Mauviel A
J Invest Dermatol; 2014 Jan; 134(1):123-132. PubMed ID: 23897276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
